LXRX Lexicon Pharmaceuticals Inc
Market Cap
458.6M
Day’s Range
52W Range
Volume (3M)
376.54K
Price-Earnings Ratio
12.52
Revenue
125K
Lexicon Pharmaceuticals Inc Latest News
Top Discussions
28
FEB
REPORTS
Lexicon Pharmaceuticals Inc Q4 2022 earnings report is expected to be released after market open

LXRX
Lexicon Pharmaceuticals Inc
2.43
-0.04
(-1.62%)

LXRX
Lexicon Pharmaceuticals Inc
2.41
-0.04 (-1.62%)
3
NOV
REPORTS
Lexicon Pharmaceuticals Inc Q3 2022 earnings report released after market open

LXRX
Lexicon Pharmaceuticals Inc
2.43
-0.04
(-1.62%)

LXRX
Lexicon Pharmaceuticals Inc
2.41
-0.04 (-1.62%)
About Lexicon Pharmaceuticals Inc
Lexicon Pharmaceuticals is a biopharmaceutical company with international operations. The company works to discover and develop precise medicines for serious, chronic conditions. Founded in 1995, the company has headquarters in The Woodlands, Texas. It is listed using the LXRX ticker on the NASDAQ GS stock market. Add the LXRX stock to your holdings to increase the diversity of your eToro portfolio.
Show More87
Employees
The Woodlands, Texas, US
HQ
1995
Founded
Lonnel Coats
CEO
Upcoming Earnings
28
FEB
REPORTS
Lexicon Pharmaceuticals Inc Q4 2022 earnings report is expected to be released after market open
Consensus
Moderate Buy
Price Target
6.00
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
43
Low
Industry
Avg. 47
31
Environment
44
Social
49
Governance
People Also Bought
RPAY Repay Holdings Corp -3.32%
- AXGN Axogen Inc. -3.02%
- CAMP CalAmp Corp. -2.22%
- CRNT Ceragon Networks Ltd -11.93%
RARE.US Ultragenyx Pharmaceutical Inc. -4.53%